Doctors Worry About Shortage of Pluvicto Medication for Prostate Cancer Patients Novartis AG is trying to boost the availability of life-extending treatment Pluvicto for advanced prostate cancer patients, but some may have to wait months. by Trisha Kae Andrada
Health World's Most Expensive Gene Therapy Zolgensma Treats Rare Genetic Disease In Infants by Alyssa Navarro
Health Novartis CAR-T Cancer Therapy For Leukemia Gets Landmark Recommendation From FDA Panel by Alyssa Navarro
Health FDA Approves Rydapt For Treatment Of Acute Myeloid Leukemia In Adult Patients by Andrew Norman
Health Gleevec Can Keep Leukemia Patients Alive For More Than 10 years, But How Much Does It Cost? by Des Luna
Healthy Living/Wellness Midostaurin In AML Improves Survival In Newly Diagnosed AML Patients by Rina Marie Doctor
Healthy Living/Wellness Novartis CART Lymphoma Therapy CTL019 Shows Positive Results In Clinical Study by Rina Marie Doctor
Healthy Living/Wellness Novartis Agrees To Pay $390 million In U.S. Settlement Over Illegal Pharmacy Kickbacks by Ted Ranosa
Healthy Living/Wellness Novartis Cancer Drug Beneficial To Parkinson's Disease Patients, Reveals Early Stage Trial by Jim Algar
Healthy Living/Wellness Swiss Drug Maker Novartis To Invest Additional $15 Million In Israel's Gamida Cell by Ted Ranosa
Healthy Living/Wellness Opdivo And Cometriq Drugs Proven More Effective Than Novartis' Afinitor As Advanced Kidney Cancer Treatment by Rhodi Lee
Healthy Living/Wellness Novartis Launches Portfolio For Low Cost Medicines For Low To Middle Income Countries by Rina Marie Doctor
Business Tech Google Teams Up With Sanofi To Improve Diabetes Management And Treatment by Lauren Keating
Healthy Living/Wellness Novartis' Entresto For Heart Failure Might Cost $4,500 A Year: What You Should Know About Heart Failure by Rina Marie Doctor
Healthy Living/Wellness Novartis Shows Long-Term Benefits Of Psoriasis Drug Cosentyx In New Set Of Clinical Data by Rhodi Lee
Healthy Living/Wellness FDA Approves First 'Biosimilar' Drug Zarxio Paving Way For More Affordable Drugs by Sumit Passary
Healthy Living/Wellness Novartis Seeks FDA Approval for New COPD Drugs Following Successful Clinical Trials by Dianne Depra
Healthy Living/Wellness Novartis Version of Amgen Cancer Drug Just as Good as Original by Dianne Depra
Healthy Living/Wellness Novartis drug LCZ696 for treating heart failure, promises to be a blockbuster by Rhodi Lee
Healthy Living/Wellness Experimental Novartis drug may reduce heart failure deaths, study reveals by Linda Nguyen
Healthy Living/Wellness New Novartis drug cuts heart failure mortality, hospital admission by Aaron Mamiit
Tech Smart contact lens closer to reality, Novartis' Alcon unit signs agreement with Google by Menchie Mendoza
Healthy Living/Wellness Google, Novartis team up to develop ‘smart’ contact lenses for diabetics by Christian Bautista
Healthy Living/Wellness Novartis reports efficacy of Signifor LAR for acromegaly after Phase III trial by Rhodi Lee
Healthy Living/Wellness Is Novartis' LCZ696 the next gold standard of heart failure drugs? by Rhodi Lee
Healthy Living/Wellness Early trial results of heart drug suggests Novartis has a winner on its hands by Tabitha Laffernis